Brickell Biotech, Inc.
https://brickellbio.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Brickell Biotech, Inc.
Two New Vaccines To Join COVID Fight As China Ships Millions Overseas
CanSino's COVID-19 vaccine is on the cusp of a formal approval in China, as is another candidate from state-owned Sinopharm. Meanwhile, China is shipping millions of doses around the world.
Coronavirus Update: EU Demands AstraZeneca Meets Its Vaccines Commitments After Supply Warning
Plus Takeda starts vaccine trial in Japan and South Korea clears Celltrion's antibody therapeutic.
China Sees No Variant Impact On Vaccines, Builds New mRNA Plant
Chinese officials do not expect the new strain of coronavirus emerging in the UK to impact the efficacy of inactivated virus vaccines on the cusp of conditional approval. Meanwhile, a new plant is under construction in China for domestically developed mRNA vaccines.
Coronavirus Update: Moderna Snags Vaccine EUA
The FDA granted emergency authorization for Moderna's mRNA-1273 following a 17 December advisory committee vote in its favor. There have also been more supply deals and approvals in Asia.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Vical, Inc.
- Vical Incorporated (VICL)